Lumbosacral Spine Sprain/Strain Injuries Medication

  • Author: Andrea Radebold, MD; Chief Editor: Craig C Young, MD   more...
 
Updated: Feb 28, 2010
 

Medication Summary

The goal of pharmacotherapy is to reduce patient morbidity and prevent complications. In acute injuries, pharmacotherapy should usually not exceed 6 weeks of treatment.

Next

Muscle relaxants

Class Summary

In the acute phase, muscle relaxants (IM injection or tablets) help to treat muscle spasms and facilitate light physical therapy.[12] However, muscle relaxants have not been shown to shorten or alter the course of the injury process.

Methocarbamol (Robaxin)

 

Exact mechanism in humans not known. May be due to general central nervous system (CNS) depression. Has no direct action on contractile mechanism of striated muscles, the motor endplate, or the nerve fiber. Indicated as an adjunct to rest, physical therapy, and other measures for the relief of the discomfort associated with acute pain and painful musculoskeletal conditions.

Previous
Next

Nonsteroidal anti-inflammatory drugs (NSAIDS)

Class Summary

NSAIDs are generally used to treat muscle pain in the acute and maintenance phases of treatment. These drugs usually have anti-inflammatory, analgesic, and antipyretic activities. The ability of NSAIDs to inhibit prostaglandin synthesis may be involved in the anti-inflammatory effect; these agents are indicated in the acute and maintenance phase of the pain treatment for lumbosacral injuries.

Selective cyclooxygenase-2 (COX-2) inhibitors are generally not recommended as first-line treatment.

Diclofenac (Voltaren)

 

Has anti-inflammatory, analgesic, and antipyretic activities. Used to treat acute and continuous pain. In general, patients should be maintained on the lowest dosage of diclofenac that is consistent with achieving a satisfactory therapeutic response.

Ibuprofen (Ibuprin, Advil, Motrin)

 

Drug has anti-inflammatory, antipyretic, and analgesic activities. Mode of action not known. However, ability to inhibit prostaglandin synthesis may be involved in anti-inflammatory effect. Smallest dose that yields acceptable control of pain should be employed. A therapy longer than 3-6 months may result in gastrointestinal bleeding or ulcers; long-term therapy must be closely observed.

Previous
Proceed to Follow-up
 
 
Contributor Information and Disclosures
Author

Andrea Radebold, MD  Research Associate, Department of Orthopaedics and Rehabilitation, Yale University School of Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Andrew D Perron, MD  Residency Director, Department of Emergency Medicine, Maine Medical Center

Andrew D Perron, MD is a member of the following medical societies: American College of Emergency Physicians, American College of Sports Medicine, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Senior Pharmacy Editor, eMedicine

Disclosure: eMedicine Salary Employment

Russell D White, MD  Professor of Medicine, Director of Sports Medicine Fellowship Program, Medical Director, Sports Medicine Center, Head Team Physician, University of Missouri-Kansas City Intercollegiate Athletic Program, Department of Community and Family Medicine, University of Missouri-Kansas City School of Medicine, Truman Medical Center Lakewood

Russell D White, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Family Physicians, American Association of Clinical Endocrinologists, American College of Sports Medicine, American Diabetes Association, and American Medical Society for Sports Medicine

Disclosure: Nothing to disclose.

Jon B Whitehurst, MD  Clinical Instructor of Surgery, University of Illinois College of Medicine; Partner, Rockford Orthopedic Associates; Orthopedic Chairman, Rockford Memorial Hospital

Jon B Whitehurst, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Orthopaedic Society for Sports Medicine, and Arthroscopy Association of North America

Disclosure: Nothing to disclose.

Chief Editor

Craig C Young, MD  Professor, Departments of Orthopedic Surgery and Community and Family Medicine, Medical Director of Sports Medicine, Sports Medicine Fellowship Director, Medical College of Wisconsin

Craig C Young, MD is a member of the following medical societies: American Academy of Family Physicians, American College of Sports Medicine, American Medical Society for Sports Medicine, and Phi Beta Kappa

Disclosure: Nothing to disclose.

References
  1. Keene JS, Albert MJ, Springer SL, Drummond DS, Clancy WG Jr. Back injuries in college athletes. J Spinal Disord. Sep 1989;2(3):190-5. [Medline].

  2. Gourmelen J, Chastang JF, Ozguler A, et al. Frequency of low back pain among men and women aged 30 to 64 years in France. Results of two national surveys. Ann Readapt Med Phys. Nov 2007;50(8):640-4. [Medline].

  3. Louw QA, Morris LD, Grimmer-Somers K. The Prevalence of low back pain in Africa: a systematic review. BMC Musculoskelet Disord. Nov 1 2007;8(1):105. [Medline].

  4. Navar D, Zhou BH, Lu Y, Solomonow M. High-repetition cyclic loading is a risk factor for a lumbar disorder. Muscle Nerve. Nov 2006;34(5):614-22. [Medline].

  5. Radebold A, Cholewicki J, Panjabi MM, Patel TC. Muscle response pattern to sudden trunk loading in healthy individuals and in patients with chronic low back pain. Spine. Apr 15 2000;25(8):947-54. [Medline].

  6. Noonan TJ, Garrett WE Jr. Muscle strain injury: diagnosis and treatment. J Am Acad Orthop Surg. Jul-Aug 1999;7(4):262-9. [Medline].

  7. Panjabi MM. The stabilizing system of the spine. Part I. Function, dysfunction, adaptation, and enhancement. J Spinal Disord. Dec 1992;5(4):383-9; discussion 397. [Medline].

  8. Cholewicki J, Panjabi MM, Khachatryan A. Stabilizing function of trunk flexor-extensor muscles around a neutral spine posture. Spine. Oct 1 1997;22(19):2207-12. [Medline].

  9. Weksler N, Velan GJ, Semionov M, et al. The role of sacroiliac joint dysfunction in the genesis of low back pain: the obvious is not always right. Arch Orthop Trauma Surg. Dec 2007;127(10):885-8. [Medline].

  10. Taimela S, Kujala UM, Osterman K. Intrinsic risk factors and athletic injuries. Sports Med. Apr 1990;9(4):205-15. [Medline].

  11. Cholewicki J, Juluru K, Radebold A, Panjabi MM, McGill SM. Lumbar spine stability can be augmented with an abdominal belt and/or increased intra-abdominal pressure. Eur Spine J. 1999;8(5):388-95. [Medline].

  12. Almekinders LC. Anti-inflammatory treatment of muscular injuries in sport. An update of recent studies. Sports Med. Dec 1999;28(6):383-8. [Medline].

  13. Demoulin C, Distrée V, Tomasella M, Crielaard JM, Vanderthommen M. Lumbar functional instability: a critical appraisal of the literature. Ann Readapt Med Phys. Nov 2007;50(8):677-84. [Medline].

  14. Garrett WE Jr. Muscle strain injuries. Am J Sports Med. 1996;24(6 suppl):S2-8. [Medline].

  15. LeBlanc KE. Sacroiliac sprain: an overlooked cause of back pain. Am Fam Physician. Nov 1992;46(5):1459-63. [Medline].

  16. Panjabi MM. The stabilizing system of the spine. Part II. Neutral zone and instability hypothesis. J Spinal Disord. Dec 1992;5(4):390-6; discussion 397. [Medline].

  17. Tall RL, DeVault W. Spinal injury in sport: epidemiologic considerations. Clin Sports Med. Jul 1993;12(3):441-8. [Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.